At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,031 enrolled
Drug / intervention
chosen TAVI valvedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Comparison of Eligible TAVI-valves - Cohort B (Sapien Versus Myval)
In Brief
A clinical study evaluating chosen TAVI valve for Transcatheter Aortic Valve Implantation. Completed, enrolled 1,031 participants across 1 site.
Detailed Summary
The study performs head-to-head comparison of two TAVI-valves: Sapien and Myval.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTranscatheter Aortic Valve Implantation
CountriesDenmark
CollaboratorsOdense University Hospital, Aalborg University Hospital
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartJun 2020
First PostedJun 2020
Primary CompletionNov 2023
Study CompletionNov 2025
TodayJul 2026
First PostedJun 23, 2020
Enrollment StartJun 15, 2020
Primary CompletionNov 2, 2023
Study CompletionNov 2, 2025
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 6.0 years ago
Interventions
chosen TAVI valvedevice
chosen TAVI valve